This does not apply to applications submitted in response to the following calls for proposals: – The BEDREHELSE programme: “NOK 40 million to joint Indo-Norwegian researcher projects on antimicrobial resistance”; – The HELSEVEL programme: “NOK 55 million for research on health and welfare educational programmes”.
NOK 40 million to Indo-Norwegian projects on antimicrobial resistance Following up the Bilateral agreement of Science and Technology between India and Norway, and the Memorandum of Understanding on Health research between the Indian Council of Medical Research and the Research Council of Norway, ICMR and RCN issue a call for …
The Indo-Norwegian research collaboration on antimicrobial resistance is historical. This is a global health challenge where knowledge and research needs are greater than any country can solve alone.
NFR is planning a joint call of the four health programs BEDREHELSE, HELSEVEL, KVINNEHELSE, BEHANDLING. • BEHANDLING: NOK 150 million for research on diagnosis, treatment and rehabilitation • KVINNEHELSE: Until 60 million to projects on women’s health. • HELSEVEL: 80 million for research on health and welfare services.
NOK 15 million for Norwegian-Indian project on antibiotic resistance . A Novel Diagnostic Tool for Sequence Based Prediction of Antimicrobial Resistance» and is a collaborative project between actors in Norway and India. who received a total of NOK 39,5 million from the Research Council. For more information, see the Research …
挪威出资4000万克朗支持中挪联合研究 NOK 40 million to joint Sino-Norwegian research. The Research Council of Norway (RCN) and the National Natural
BEDREHELSE: NOK 40 million to joint Indo-Norwegian researcher projects on antimicrobial resistance. Deadline : 26 April 2017 HELSEVEL : 55 million for research on health and welfare educational programs .
Four joint Indo-Norwegian researcher projects within bio economy By Ugo have started a program for joint funding of Indo-Norwegian joint research projects in mutually agreed fields to achieve world-class scientific results. C.R. Edit- CRISPR/Cas9 edition to test and control genes implicated in influencing Aeromonas disease resistance in
ICMR is soliciting collaborative research projects in the field of antimicrobial resistance. ICMR will fund the Indian component of the studies and will collaborate on this initiative with RCN. Support will be for a maximum of two years.
NIH and ASPR/BARDA each contributed $10 million to the challenge. Norway committed to finance six research projects for a total of NOK 40 million (about 4.9 million USD) regarding AMR in collaboration with the Indian Council of Medical Research. Projects include new leads for antibiotics, diagnostics for prediction of AMR, among others.